Clinical Trial Update: Safety and Efficacy Study of DuoTrav APS Versus DuoTrav [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial comparing DuoTrav APS to DuoTrav was withdrawn, involving open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))
• DuoTrav APS

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: WITHDRAWN